Lataa...
Combating emerging viral threats
Most approved antiviral therapeutics selectively inhibit proteins encoded by a single virus, thereby providing a “one drug-one bug” solution. As a result of this narrow spectrum of coverage and the high cost of drug development, therapies are currently approved for fewer than ten viruses out of the...
Tallennettuna:
| Julkaisussa: | Science |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4419706/ https://ncbi.nlm.nih.gov/pubmed/25883340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.aaa3778 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|